NCT06186596View on ClinicalTrials.gov

Self-Administered Intralesional Injections for Acne

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Acne Vulgaris
Interventions
DEVICE

Triamcinolone delivered via injection assistance device

0.1mL of 1% to 2% triamcinolone solution will be delivered to up to 3 facial inflammatory acne lesions

Trial Locations (3)

33021

COMPLETED

Skin Care Research, Hollywood

33486

RECRUITING

Skin Care Research, Boca Raton

94538

RECRUITING

Center For Dermatology Clinical Research, Inc, Fremont

Sponsors

Lead Sponsor

ACOM Labs
All Listed Sponsors
lead

ACOM Labs

INDUSTRY